The Medical Device Connectivity market involves technology and software that enables networking between medical devices in healthcare facilities and clinical information systems for effective data management. Medical Device Connectivity allows clinicians to access patient data on vitals such as blood pressure, temperature, heart rate, and oxygen levels remotely and in real-time. This assists clinicians in timely diagnosis and treatment. Additionally, Medical Device Connectivity helps reduce manual documentation errors and improves workflow efficiency. The global connectivity of medical devices aids hospitals and healthcare centers in streamlining operations and improving patient safety.
Global Medical Device Connectivity market is estimated to be valued at US$ 3.5 Billion in 2023 and is expected to exhibit a CAGR of 25.8% during the forecast period (2023-2030).
Key Takeaways
Key players operating in the Medical Device Connectivity are Diabetomics, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, PerkinElmer Inc., Siemens Healthineers AG, DRG INSTRUMENTS GMBH, Metabolomic Diagnostics Ltd., Sera Prognostics, MOMM Diagnostics, Miraculins Inc. These players are focusing on developing advanced connectivity solutions to integrate medical devices with healthcare IT systems.
The Medical Device Connectivity Market Growth for integrated healthcare is boosting the Medical Device Connectivity market. Patients are increasingly relying on remote and home healthcare options using connected medical devices. This is driving the need for seamless networking of medical equipment with clinical databases. Furthermore, the rising prevalence of chronic diseases is also propelling the demand for Medical Device Connectivity solutions to efficiently manage high-risk patients.
Get More Insights on- Medical Device Connectivity market
